Subjects |
Age |
Cervix |
Vulva |
Anal |
Vagina |
Urethra/bladder |
Oropharyngeal |
Cervix IS |
Vulva IS |
Oro IS |
HAART Compliance |
CD4>200 |
Patient navigator |
Survival |
1 |
45 |
x |
x |
|
|
|
x |
|
|
|
|
|
|
27 |
2 |
52 |
|
x |
|
|
|
|
X |
|
|
x |
x |
x |
N/A |
3 |
50 |
x |
|
x |
|
|
x |
|
x |
|
|
|
|
19 |
4 |
34 |
x |
x |
|
|
|
|
|
|
x |
x |
x |
x |
N/A |
5 |
30 |
|
|
x |
|
|
|
X |
|
|
x |
x |
x |
N/A |
6 |
35 |
x |
|
|
|
X |
|
|
|
|
|
|
|
21 |
7 |
37 |
|
|
|
x |
|
|
X |
|
|
x |
x |
x |
N/A |
8 |
51 |
x |
x |
|
x |
|
|
|
|
|
|
|
|
9 |
9 |
29 |
|
|
|
x |
|
|
|
|
|
x |
x |
x |
N/A |
10 |
45 |
|
x |
|
|
|
|
|
|
|
x |
x |
x |
N/A |
11 |
38 |
x |
|
|
|
|
x |
|
x |
|
x |
|
|
13 |
12 |
33 |
x |
|
|
|
|
|
|
|
|
x |
x |
x |
N/A |
13 |
60 |
|
|
x |
|
|
|
X |
|
|
x |
x |
x |
N/A |
14 |
32 |
x |
x |
|
|
X |
|
|
|
|
x |
x |
x |
N/A |
15 |
30 |
|
|
|
|
|
|
|
|
|
x |
x |
x |
N/A |
16 |
36 |
x |
|
x |
|
|
|
|
x |
|
x |
x |
x |
28 |
17 |
28 |
|
x |
|
|
|
|
|
|
|
|
|
|
18 |
The long-term incidence and mortality from cancer in women with HIV and cervical dysplasia in this small cohort appears to be comparable to that seen in the general population, with the possible exception of oropharyngeal cancers. Compliance with cancer screening recommendations appears to be higher than in the general population. This suggests that structured primary care programs for HIV-infected women are effective in prevention/early diagnosis of cancer. Standardized screening programs for oropharyngeal cancers should be considered in this population.
Citation: Rogg K, Richter MA, Robinson WR (2018) Human Papilloma Virus (HPV) - Related Cancers in Human Immunodeficiency Virus - Infected Women with a History of Cervical Dysplasia. J AIDS Clin Res Sex Transm Dis 5: 021.
Copyright: © 2018 Rogg K, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.